Citi Starts Dermira (DERM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oil jumps to $105 a barrel after Middle East tanker attacks escalate
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
- This is Morgan Stanley's only preferred sportswear stock
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- White House copper tariff plan stalls amid affordability concerns, sources say
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Guggenheim Starts Dermira (DERM) at Buy
October 28, 2014 7:50 AM EDTGuggenheim initiated coverage on Dermira (NASDAQ: DERM) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Dermira click here. For more ratings news on Dermira click here.
Shares of Dermira closed at $15.50 yesterday.
... MoreLeerink Swann Starts Dermira (DERM) at Outperform
October 28, 2014 7:49 AM EDTLeerink Swann initiated coverage on Dermira (NASDAQ: DERM) with an Outperform rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Dermira click here. For more ratings news on Dermira click here.
Shares of Dermira closed at $15.50 yesterday.
... MoreNeedham & Company Starts Dermira (DERM) at Buy
October 28, 2014 6:27 AM EDTNeedham & Company initiates coverage on Dermira (NASDAQ: DERM) with a Buy rating and a price target of $23.00.
Analyst Elliot Wilbur said, "We are initiating coverage of Dermira (DERM), an emerging spec pharma leader in dermatology. We believe DERM is endowed with "rock star"... More
